Originally formed to commercialize suppressor oncogene technology developed by Dr. Wen-Hwa Lee of the University of California at San Diego. Canji, Inc. is a biotechnology company which develops innovative therapeutics based on tumor suppressor genes, cell-cycle regulators and growth modulators. As of February 1, 1996, became a wholly owned subsidiary of Schering-Plough Corporation